Guañabens, Núria http://orcid.org/0000-0002-7103-9530
,
Moro-Álvarez, María Jesús
Casado, Enrique
Blanch-Rubió, Josep
Gómez-Alonso, Carlos
Díaz-Guerra, Guillermo Martínez
del Pino-Montes, Javier
Valero Díaz de Lamadrid, Carmen
Peris, Pilar
Muñoz-Torres, Manuel
Article History
Received: 28 January 2019
Accepted: 29 March 2019
First Online: 8 April 2019
Compliance with ethical standards
:
: Dr. N.G. has received fees for lectures and participation in advisory boards from Amgen, Eli Lilly, Alexion, and UCB. Dr. E.C. has received fees for lectures and/or participation in advisory boards from Amgen, Lilly, UCB and Rubió. Dr. J.B.-R. has received advisory fees from Amgen and Gebro Pharma. Dr. C.G.-A. has received fees for lectures and participation in advisory boards from Amgen, Eli Lilly, Faes, Gebro, and UCB. Dr. G.M.D.-G. holds a research grant from Amgen and Shire, has received advisory fees from Amgen, UCB, Eli Lilly, and Shire and speaker honoraria from Amgen and Eli Lilly. Dr. J.d.P.-M. has received advisory and conference fees, as well as congress grants from Amgen, UCB, and FAES and conference fees from Eli Lilly and Gebro. Dr. P.P. has received lecture fees from Amgen, Eli Lilly, Alexion, and Kyowa Kirin. Dr. M.M.-T. has received fees for lectures and advisory boards from Amgen, UCB, Eli Lilly, Alexion, Shire, and Kyowa Kirin.